Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chinese Academy of Sciences Holdings (CASH) is the primary investment and management arm of the Chinese Academy of Sciences (CAS). Established to bridge the gap between scientific research and industrial application, the company manages a vast portfolio of high-tech enterprises across various sectors, with a significant focus on life sciences, biotechnology, and healthcare. CASH oversees the commercialization of intellectual property generated by CAS institutes, fostering the development of innovative therapies, medical devices, and diagnostic tools. Through its subsidiaries and investment funds, the company plays a pivotal role in the growth of China's domestic biotech ecosystem and international scientific collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Development Chinese Academy of Sciences.